Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026

Fierce Biotech, a Division of Forge, Names SonoThera a “Fierce 15” Biotech Company of 2026

SAN FRANCISCO--(BUSINESS WIRE)--Oct 5, 2026-

Sironax Named to Fierce Biotech’s “Fierce 15” List of the Most Innovative and Promising Private Biotechs of 2026

Recognized for bold approach to addressing therapeutic targets

Freya Biosciences named as one of Fierce Biotech’s “Fierce 15” for 2026

Recognition reflects Freya’s scientific progress and commitment to addressing significant unmet needs in women’s health Copenhagen, Denmark and Boston, Massachusetts, 5 October 2026: Freya Biosciences (“Freya” or “the Company”), a clinical-stage immunology company developing therapies to treat inflammation and immune dysregulation in women, today announces that Fierce Biotech, a division of Forge, has named it […]